Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Day 364: war diaries w/Former Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    Day 364: war diaries w/Former Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Joint Statement on the Eighth Round of the Strategic Dialogue between Romania and the United States
    Joint Statement on the Eighth Round of the Strategic Dialogue between Romania and the United States World News
  • Boutique Gourmet Chocolate Brand Ticket Chocolate Ranks No. 150 on Inc. Magazine’s List of the Pacific Region’s Fastest-Growing Private Companies
    Boutique Gourmet Chocolate Brand Ticket Chocolate Ranks No. 150 on Inc. Magazine’s List of the Pacific Region’s Fastest-Growing Private Companies Business
  • Aircraft Cabin Lighting Market 2025 : Competitive Analysis and Industry Forecast
    Aircraft Cabin Lighting Market 2025 : Competitive Analysis and Industry Forecast Business
  • Stephen Nalley, Distinguished Entrepreneur and Expert Negotiator, Launches a Masterful Guide on the Art of Negotiation
    Stephen Nalley, Distinguished Entrepreneur and Expert Negotiator, Launches a Masterful Guide on the Art of Negotiation Business
  • Sales Talent Wins ClearlyRated’s 2023 Best of Staffing Client and Talent Awards With NPS Scores of +90% and +84%
    Sales Talent Wins ClearlyRated’s 2023 Best of Staffing Client and Talent Awards With NPS Scores of +90% and +84% Business
  • Unlocking Global Gaming Potential for Brands
    Unlocking Global Gaming Potential for Brands World News
  • Sifter Offers a Technology Solution in Response to White House Call to Action on Hunger, Nutrition, and Health
    Sifter Offers a Technology Solution in Response to White House Call to Action on Hunger, Nutrition, and Health Business
DiaGen Ai Inc. Announces Partnership with Cambridge, UK Based The Vaccine Group LTD. to Co-Develop Novel Vaccines

DiaGen Ai Inc. Announces Partnership with Cambridge, UK Based The Vaccine Group LTD. to Co-Develop Novel Vaccines

Posted on May 12, 2024 By NewsEditor

VANCOUVER, BC, CANADA, May 1, 2024 /EINPresswire.com/ — DiaGen Ai Inc. Announces Partnership with Cambridge, UK Based The Vaccine Group LTD. to Utilise its Proprietary AI Engine to Evaluate and Co-Develop Novel Vaccines Addressing Unmet Needs in the Veterinary Market

Vancouver, British Columbia–(EIN Presswire. – May 1, 2024) – DiaGen AI Inc. (“DiaGen” or the “Company”) founded in 2021 to advance its proprietary Artificial Intelligence (“AI”) engine in protein design, drug discovery and diagnostics for health, wellness, longevity, and precision medicine is pleased to announce it has signed a Technology Evaluation Agreement (“TEA”) with Cambridge, UK based The Vaccine Group (“TVG”) to advance its novel veterinary vaccine pipeline.

“The Partnership with DiaGen will bring strong complimentary AI approaches to develop novel and improved vaccines. TVG’s herpesviral vector delivery system will be used to deliver transgenes designed for expression of optimal antigenic proteins in animal patients. Initial focus will be on the development of broadly protective vaccine candidates for a disease caused by a highly variable virus. This new partnership with DiaGen represents a significant development in TVG’s ability to address key gaps in the veterinary vaccine market,” said Jeremy Salt, TVG CEO.

“We are excited to further iterate our proprietary Ai capabilities into a new addressable market in the Veterinary sector to optimize the ideal protein structures for expression and immune stimulation to complement TVG’s experienced team in advancing their vaccine pipeline,” said Paolo Lobo, DiaGen’s President.

Both DiaGen and TVG are portfolio companies of publicly traded Frontier IP Group PLC (LON:FIPP) who introduced the parties to advance their collaboration and partnership.

For more information about DiaGen Ai Inc., please visit www.diagen.ai

Or

Contact us:

Brian D. Keane, Chairman and CEO Email: [email protected]

For more information about The Vaccine Group Ltd., please visit www.thevaccinegroup.com

Or

Contact

Jeremy Salt, CEO Email: [email protected]

Forward-Looking Statement Cautions

This press release contains certain “forward-looking statements” within the meaning of Canadian securities legislation, relating to the Company’s plans and expectations. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words “expects,” “plans,” “anticipates, ” “believes,” “intends, ” “estimates,” “projects,” “aims,” “suggests,” “indicate,” “often,” “target,” “future,” “likely,” “pending,” “potential,” “goal,” “objective, ” “prospective, ” and “possibly,” and similar expressions, or that events or conditions “will,” “would,” “may,” “can,” “could” or “should” occur, or are those statements, which, by their nature, refer to future events. Forward-looking statements in this news release include statements relating to: the Company’s ability to make advancements in industry using its proprietary DIA technology; the Company’s focus on the AI sector; the Company providing a return on investment for its shareholders; and the continued growth of the Company, viability of its DIA technology; general applicability of AI technology towards the healthcare sector, particularly drug discovery, diagnostics, and vaccines; the ability of the Company to find strategic acquisitions and consummate transactions to acquire such entities; and the ability of the Company to use its technology to make a meaningful impact on the healthcare industry.

The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made, and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Except to the extent required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements if management’s beliefs, estimates or opinions, or other factors, should change. Factors that could cause future results to differ materially from those anticipated in these forward-looking statements that the Company will not be able to raise sufficient funds to carry out its business plans, and the risk of political uncertainties and regulatory or legal changes that might interfere with the Company’s business and prospects.

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Company’s ability to make advancements in industry using its proprietary DIA technology; the Company’s expectation of growth of the AI sector as it applies to healthcare; the Company’s ability to provide a return on investment for its shareholders; the continued growth of the Company; the viability of the Company’s DIA technology; the continued applicability of AI technology within the healthcare sector, particularly drug discovery, diagnostics, and vaccines; the ability of the Company to find strategic acquisitions and consummate transactions to acquire such entities; and the ability of the Company to use its technology to make a meaningful impact on the healthcare industry.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward- looking information, except as required by applicable law.

Brian Keane
Diagen AI Inc
+1 201-736-3590
[email protected]
Visit us on social media:
Twitter
LinkedIn
Instagram

DiaGen Ai Inc. Announces Partnership with Cambridge, UK Based The Vaccine Group LTD. to Co-Develop Novel Vaccines

You just read:

News Provided By

May 01, 2024, 14:00 GMT

Distribution channels:
Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry, Companies, Consumer Goods, Healthcare & Pharmaceuticals Industry, Media, Advertising & PR, Science, Social Media, Technology, World & Regional
…


EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content.
As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswire™,
tries to define some of the boundaries that are reasonable in today’s world. Please see our
Editorial Guidelines
for more information.



Article originally published on www.einpresswire.com as DiaGen Ai Inc. Announces Partnership with Cambridge, UK Based The Vaccine Group LTD. to Co-Develop Novel Vaccines

World News

Post navigation

Previous Post: ESET Announces Integration with Arctic Wolf to Deliver Next-Gen Detection and Response for Businesses
Next Post: Dream Quest Foundation takes center stage

Related Posts

  • Ukraine War, Analytics. Day 880: Real Price For Peace in Ukraine – Neutrality. Arestovych, Feldman
    Ukraine War, Analytics. Day 880: Real Price For Peace in Ukraine – Neutrality. Arestovych, Feldman World News
  • In recognition of her long-standing dedicated service, Family Lawyer Minji Kim received the KCSC Community Service Award
    In recognition of her long-standing dedicated service, Family Lawyer Minji Kim received the KCSC Community Service Award World News
  • Day 147 – Latynina.tv – Alexey Arestovych
    Day 147 – Latynina.tv – Alexey Arestovych World News
  • War Day 251: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin
    War Day 251: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin World News
  • Secretary Antony J. Blinken And Kyrgyz Republic Foreign Minister Jeenbek Kulubaev Before Their Meeting
    Secretary Antony J. Blinken And Kyrgyz Republic Foreign Minister Jeenbek Kulubaev Before Their Meeting World News
  • Assistant Secretary for South and Central Asian Affairs Donald Lu and Assistant Secretary for Economic and Business Affairs Ramin Toloui, Previewing Secretary Blinken’s Upcoming Travel to Kazakhstan, Uzbekistan, and India
    Assistant Secretary for South and Central Asian Affairs Donald Lu and Assistant Secretary for Economic and Business Affairs Ramin Toloui, Previewing Secretary Blinken’s Upcoming Travel to Kazakhstan, Uzbekistan, and India World News
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Jul    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • LATIFF 2025 Sets New Standard for International Film Festivals with Impact-Driven Cinema and World-Class HonorsAugust 31, 2025
  • Akropin Unveils Insights on How AI Is Shaping the Future of MarketingAugust 31, 2025
  • Aviation (MRO) Market Size to Reach $145.28 Billion by 2034, Sustained by 4.82% CAGRAugust 30, 2025
  • NYC Second Chance Rescue Holds 4th Annual Hamptons Benefit ‘Concert for a Cause’August 30, 2025
  • Economic Club of Las Vegas to Host ‘Governor Fireside Chat’ LuncheonAugust 30, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Madison Museum of Contemporary Art Presents DARK MATTER, an Exhibition Featuring Celebrated Works by British Artist Faisal Abdu’Allah
    Madison Museum of Contemporary Art Presents DARK MATTER, an Exhibition Featuring Celebrated Works by British Artist Faisal Abdu’Allah Business
  • Sip Tequila Corrido This National Tequila Day
    Sip Tequila Corrido This National Tequila Day Business
  • Neurostimulation Devices Market Is Expected To Reach US.25 Billion by 2026
    Neurostimulation Devices Market Is Expected To Reach US$11.25 Billion by 2026 Business
  • Award-Winning Writers and Illustrators of the Future Experience Live Performance of L. Ron Hubbard’s Pulp Fiction Story
    Award-Winning Writers and Illustrators of the Future Experience Live Performance of L. Ron Hubbard’s Pulp Fiction Story World News
  • STEM Scholars compete for more than 0,000 in Scholarships and Awards During State Science Day Celebration 2024
    STEM Scholars compete for more than $500,000 in Scholarships and Awards During State Science Day Celebration 2024 World News
  • The Fed should not vary interest rates from normal levels, says author Nassim Taleb
    The Fed should not vary interest rates from normal levels, says author Nassim Taleb World News
  • Global Liver Diseases Therapeutics Market Size, Share, And Growth Analysis For 2024-2033
    Global Liver Diseases Therapeutics Market Size, Share, And Growth Analysis For 2024-2033 Business
  • HeadBox Offers a Proactive Way for Sydney Venues to Fill Up Christmas Event Schedules
    HeadBox Offers a Proactive Way for Sydney Venues to Fill Up Christmas Event Schedules Business
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .